RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Tavistock Life Sciences
T

Tavistock Life Sciences portfolio

Tavistock Life Sciences has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Atreca's $125M Series B+ round in September 2018, alongside Wellington Management, Tekla Capital Management, Samsara Biocapital and 5 others. That company is in Health and bio.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $125M.
Latest deal: Atreca · Sep 12, 2018.

What Tavistock Life Sciences invests in

How Tavistock Life Sciences invests

StageDealsCapital in rounds
Series B+ 1 100%$125M

Share is of the 1 round on Recent Funding that name Tavistock Life Sciences. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Tavistock Life Sciences portfolio companies

CompanyRound with Tavistock Life SciencesTotal raisedLatest raise
AAtreca
Health and bio
Series B+ · $125M$181MFeb 5, 2026
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Tavistock Life Sciences, which is a subset of its real portfolio. API: /api/v1/investors/tavistock-life-sciences (get a free API key). More: the most active VC firms and new venture capital funds.